HLN
Haleon plc
NYSE · Healthcare · Drug Manufacturers - Specialty & Generic · GB
$9.60
−2.64%Margins
Gross margin
65.1%
EBITDA margin
25.8%
EBIT margin
22.7%
Net margin
14.6%
FCF margin
10.2%
17.4%
Return on equity
8.7%
Return on assets
18.0%
Return on invested capital
0.60x
Asset turnover
$3.1B
Cash from operations
$0.25
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026